Recent Posts
- FDA Okays Blood Test for Ovarian Cancer
- Replication At DNA Damage Sites Highlights Fanconi Anemia And Breast Cancer Proteins
- ASCO To Hold Annual Meeting In Chicago For The Next Ten Years: City Seen As Best Choice To Host Meeting That Continues To Grow
- Protein Partnership Leads To Pediatric Tumor Regression
- ASCO Awarded CEO Cancer Gold Standard: Achievement Underscores Organization’s Commitment To The Health And Well-Being Of Its Employees
Random Posts
- Approved Lymphoma Drug Shows Promise In Early Tests Against Bone Cancer
- Cancer Risk May Be Greater With Insulin Analogue Glargine
- Stanford, Palo Alto Medical Foundation Launch Comprehensive Breast Cancer Study
- 94 New Research And Training Grants Awarded By American Cancer Society Awards To 61 Institutions Nationwide
- City-Dwellers Have Higher Risk Of Late-Stage Cancer Than Rural Residents
- Internationally Renowned Physician-Scientist Joins USC Norris Cancer Center And Keck School Of Medicine
- House Bill To Provide Cancer Patients With Solution For Quality Cancer Care Within An Equitable Medicare Model
- Cancer's Distinctive Pattern Of Gene Expression Could Aid Early Screening And Prevention
- Late-Stage Cancer: Big City, Big Risk
- K-State Biologist To Further Study Of Cellular Process That Plays Role In Chronic Disease
Prescription Cancer Drugs
AUA: Dutasteride Works Against Prostate Cancer
Posted by: admin in Cancer Treatment, Prescription Cancer Drugs on May 04th, 2009
CHICAGO, April 29 — Prostate cancer incidence decreased by 23% in high-risk men treated with dutasteride (Avodart), according to results of an international clinical trial.
Action Points